摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(1H-Benzoimidazol-2-ylsulfanyl)-1-{4-[2-(1H-benzoimidazol-2-ylsulfanyl)-acetyl]-piperazin-1-yl}-ethanone | 345987-82-8

中文名称
——
中文别名
——
英文名称
2-(1H-Benzoimidazol-2-ylsulfanyl)-1-{4-[2-(1H-benzoimidazol-2-ylsulfanyl)-acetyl]-piperazin-1-yl}-ethanone
英文别名
2-(1H-benzimidazol-2-ylsulfanyl)-1-[4-[2-(1H-benzimidazol-2-ylsulfanyl)acetyl]piperazin-1-yl]ethanone
2-(1H-Benzoimidazol-2-ylsulfanyl)-1-{4-[2-(1H-benzoimidazol-2-ylsulfanyl)-acetyl]-piperazin-1-yl}-ethanone化学式
CAS
345987-82-8
化学式
C22H22N6O2S2
mdl
——
分子量
466.588
InChiKey
OQUCRTJLOGTNPA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    32
  • 可旋转键数:
    6
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    149
  • 氢给体数:
    2
  • 氢受体数:
    6

反应信息

  • 作为产物:
    描述:
    哌嗪噻唑并[2,3-b]苯并咪唑-3(2H)-酮乙醇 为溶剂, 反应 3.0h, 以48%的产率得到2-(1H-Benzoimidazol-2-ylsulfanyl)-1-{4-[2-(1H-benzoimidazol-2-ylsulfanyl)-acetyl]-piperazin-1-yl}-ethanone
    参考文献:
    名称:
    Antihelminthic activity of some newly synthesized 5(6)-(un)substituted-1H-benzimidazol-2-ylthioacetylpiperazine derivatives
    摘要:
    Piperazine derivatives of 5(6)-substituted-(1H-benzimidazol-2-ylthio)acetic acids were synthesized by using two methods and studied for antihelminthic activity.The antiparasitic screening showed that compounds 18-24 exhibited higher activity against Trichinella spiralis in vitro in comparison to methyl 5-(propylthio)-1H-benzimidazol-2-yl-carbamate (albendazole). Most active were compounds 2-({2-[4-(4-chlorophenyl)piperazin-1-yl]-2-oxoethyl}thio)-1H-benzimidazole 21 and 2-{[2-oxo-2-(4-benzhydrylpiperazin-1-yl)ethyl]thio}-5(6)-methyl-1(H)-benzimidazole 19 as well as 2-({2-[4-(4-chlorophenyl)piperazin-1-yl]-2-oxoethyl}thio)-5(6)-methyl-](H)-benzimidazole 23 with efficacy of 96.0%, 98.4% and 100%, respectively.The tested derivatives 15-19 and 20-23 were less active against Syphacia obvelata in vivo than albendazole and exhibited the same efficacy as piperazine, but in twice lower concentration. Compounds 2-({2-[4-(4-chlorophenyl)piperazin-1-yl]-2-oxoethyl}thio)-1H-benzimidazole 21, 1,4-bis[(5(6)-methyl-l(H)-benzimidazol-2-ylthio)acetyl]piperazine 17 and 2-({2-[4-(4-chlorophenyl)piperazin-1-yl]-2-oxoethyl)thio)-5(6)-methyl- 1(H)-benzimidazole 23 had higher efficacies of 73%, 76%, and 77%, respectively. (c) 2006 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2006.07.005
点击查看最新优质反应信息

文献信息

  • Antihelminthic activity of some newly synthesized 5(6)-(un)substituted-1H-benzimidazol-2-ylthioacetylpiperazine derivatives
    作者:Anelia Ts. Mavrova、Kamelya K. Anichina、Dimitar I. Vuchev、Jordan A. Tsenov、Pavletta S. Denkova、Magdalena S. Kondeva、Mitka K. Micheva
    DOI:10.1016/j.ejmech.2006.07.005
    日期:2006.12
    Piperazine derivatives of 5(6)-substituted-(1H-benzimidazol-2-ylthio)acetic acids were synthesized by using two methods and studied for antihelminthic activity.The antiparasitic screening showed that compounds 18-24 exhibited higher activity against Trichinella spiralis in vitro in comparison to methyl 5-(propylthio)-1H-benzimidazol-2-yl-carbamate (albendazole). Most active were compounds 2-(2-[4-(4-chlorophenyl)piperazin-1-yl]-2-oxoethyl}thio)-1H-benzimidazole 21 and 2-[2-oxo-2-(4-benzhydrylpiperazin-1-yl)ethyl]thio}-5(6)-methyl-1(H)-benzimidazole 19 as well as 2-(2-[4-(4-chlorophenyl)piperazin-1-yl]-2-oxoethyl}thio)-5(6)-methyl-](H)-benzimidazole 23 with efficacy of 96.0%, 98.4% and 100%, respectively.The tested derivatives 15-19 and 20-23 were less active against Syphacia obvelata in vivo than albendazole and exhibited the same efficacy as piperazine, but in twice lower concentration. Compounds 2-(2-[4-(4-chlorophenyl)piperazin-1-yl]-2-oxoethyl}thio)-1H-benzimidazole 21, 1,4-bis[(5(6)-methyl-l(H)-benzimidazol-2-ylthio)acetyl]piperazine 17 and 2-(2-[4-(4-chlorophenyl)piperazin-1-yl]-2-oxoethyl)thio)-5(6)-methyl- 1(H)-benzimidazole 23 had higher efficacies of 73%, 76%, and 77%, respectively. (c) 2006 Elsevier Masson SAS. All rights reserved.
查看更多